Skip to main content
. 2011 Jun;90(6):752–758. doi: 10.1177/0022034511399908

Figure 4.

Figure 4.

Barplots displaying three clusters based on levels of salivary biomarkers, biofilm, serum biomarkers, and clinical measures. Within each cluster, the number of participants undergoing disease progression (≥ 2 sites demonstrating > 2 mm of CAL loss over 6 mos) is indicated. Np = number of participants within each group experiencing disease progression. Ns = number of participants within each group without disease progression.